Pfizer and Valneva report positive results in mid-stage trial of Lyme disease vaccine
The Phase 2 trial was evaluating the vaccine called VLA15 following a second booster dose given one year after the first one.
The market is getting less efficient. Ape this strategy from meme-stock investors, veteran fund manager says
Don’t despair, but ape this strategy from meme-stock investors, says Clifford Asness.
September is historically the worst month for U.S. stocks. What investors need to know.
If the past is any guide, seasonal weakness in September could spoil the stock market’s momentum via a heightened level of volatility.
Why Trump’s economic populism won’t bring Americans lasting prosperity
Populism is spreading worldwide, but its leaders show little understanding of economic and geopolitical realities.
Nvidia’s earnings reveal weak spots and leave openings for its fiercest rivals
Delay with Nvidia’s new Blackwell chip gives AMD and others an advantage.
Sphere stock falls after Benchmark downgrade
Shares of Sphere Entertainment Co. are down 3.5% in premarket trade Tuesday after the entertainment and media company received a downgrade from Benchmark.
Halliburton’s stock dips after company says recent cyberattack disrupted its business
Halliburton Co.’s stock fell 1% early Tuesday, after the oil services provider said the recent cyberattack has disrupted and limited access to some of its...
Oil prices slide as weak China data overshadows Libya supply disruptions
Oil futures fell Tuesday as U.S. traders returned from a three-day holiday weekend, with weak economic data from China, the world’s largest crude importer, overshadowing...
Your pumpkin spice latte is souring the market on stocks
Fall in the air can bring falling stock prices.